VIRTUAL ISPRM 2021 · 2021. 6. 1. · 2 VIRTUAL ISPRM 2021 Congress Furthering Rehabilitation in a New World WELCOME Dear ISPRM members, Colleagues and Friends, On behalf of the President’s

VIRTUALISPRM 2021 Congress

Furthering Rehabilitation in a New World

12/15 June 2021

www.virtualisprm2021.com

FINAL PROGRAM

2




WEL

COM

E

Dear ISPRM members, Colleagues and Friends,

On behalf of the President’s Cabinet, it is my pleasure to invite you to participate in the Virtual Congress of ISPRM 2021, which will be held online on 12-15 June, 2021.

Because of the pandemic of Covid-19, the scheduled Lisbon Congress in 2021 will be postponed

to 2022. Instead, ISPRM will hold an online congress in 2021. It will be a new experience for ISPRM

Congress. Although it is delivered in digital format, the scientific content will be as good as previous

ISPRM World Congresses and with the advancement of technology, interpersonal communication

or exchange could be maintained through the platform on the web.

The theme of the congress is “Furthering Rehabilitation in a New World” which signifies the

rapid advancement in Physical and Rehabilitation Medicine to deal with scenarios and challenges

that we will encounter in the new world. The digital format of this Congress is a tool and opportunity

that ISPRM could reach out to many different parts of world. Please encourage your colleagues

and rehabilitation team members to submit abstracts and participate.

Finally, we sincerely invite you to visit the website www.virtualisprm2021.com where you would

find all the updates about the ISPRM 2021 Congress in real time.

Best regards,

ISPRM President 2020-2022Leonard S. W. LIFRCP (Lon), FRCP (Edin), FAFRM (RACP), FHKCP FHKAM (Med)

http://www.virtualisprm2021.com


3




PRESIDENT’S CABINET

CONGRESS SCIENTIFIC COMMITTEE

Leonard LiPresident

Levent ÖzçakarTurkey

Chair CSC - ISPRM 2021 Virtual World Congress

Walter FronteraPast President

Catarina Aguiar BrancoPortugal

Member - Europe, Eastern Mediterranean, Africa

Francesca GimiglianoPresident-Elect

Paolo CapodaglioItaly

Vice-Chair CSC -ISPRM 2021 Virtual World Congress

Carolina SchiappacasseTreasurer

Eleftheria AntoniadouGreece


Gerard FranciscoVice President

Wee Tze ChaSingapore

Member - Asia and Oceania

Isabelle LaffontSecretary

Ke-Vin ChangTaiwan


COM

MIT

TEES


4





Alessandro De SireItaly


Mario GiraldoColombia

Member - The Americas

Steven FauxAustralia


Tsz Kin KwokHong Kong


Catherine DziriTunisia


Ziad HawamdehJordan


Marco FranceschiniItaly


Se Won LeeUSA


Gerold EbenbichlerAustria


Isacc Hernandez JimenezUSA


Lynn GreberUSA


Su Yi LeeAustralia


COM

MIT

TEES


5





Philippe MarqueFrance


Simon TangTaiwan


Manoj PoudelUSA


Veronica MatassaArgentina


Taslim UddinBangladesh


Reynaldo Rey-MatiasPhilippines


Marta Supervia PolaSpain


Sanjay WadhwaIndia


Larry RobinsonCanada


Richard WilsonUSA


Sam WuUSA


COM

MIT

TEES


6




TIM

ETA

BLE

CEST ROOM 111:0012:00 Pharmacology of Post-stroke Recovery

12:0513:05 Rehabilitation for the Aged: Nutrition, Exercise and Others

13:1514:15 The Role of Rehabilitation in Critical Care Setting

14:2015:20 Medical Rehabilitation in Pandemic Response: A Global Priority

15:3016:30 Telemedicine in Cancer Rehabilitation

16:3517:35 Stem Cell Therapy in Acute Neurological Injury: the new frontier

CEST ROOM 1 CEST ROOM 211:0012:00 OPENING

12:0513:05 Acute Setting 12:05

13:08Oral presentations

NON CME SESSION13:1514:15 Stroke - I 13:15

14:15 Stroke - II

14:2015:20 Spinal Cord Injury 14:20

15:20 Technology - Innovation

15:3016:30 Spasticity 15:30

16:30 Scoliosis

16:3517:35 Limb Loss 16:35

17:35 Cerebral Palsy

17:4018:40 INDUSTRY-SPONSORED SYMPOSIUM 17:40

18:40 INDUSTRY-SPONSORED SESSION

SATURDAY 12

SUNDAY 13


7




TIM

ETA

BLE

CEST ROOM 1 CEST ROOM 211:0012:00 Low Physical Activity 11:00

12:00Medical Leadership: The Way Forward

in Overcoming Adversities

12:0513:05 Sports 12:05


NON CME SESSION

13:1515:20

Awards Ceremony NON CME SESSION

15:3016:30 USPRM Task Force 15:30


NON CME SESSION

16:3517:35 ISarcoPRM Special Interest Group 16:35


NON CME SESSION17:4018:40 INDUSTRY-SPONSORED SYMPOSIUM

CEST ROOM 1 CEST ROOM 2

11:0012:00 Interventions - I 11:00

12:00

Current Status of Chronic Myofascial Pain Syndrome: Evidence-informed Diagnosis

and Management

12:0513:05 Interventions - II 12:05

13:05

Advanced Concepts and Rehabilitation Approaches for Chronic Pelvic Pain

in Women

13:1514:15 Interventions - III 13:15

14:15

The ISPRM strategy to collaborate with the World Health Organization; the ISPRM WHO liaison committee

activities report

14:2015:20

An Introduction to Cancer Rehabilitation from the Advocacy, Clinical Practice,

Education, and Research Perspectives

14:2015:20

WHO Rehabilitation Competency Framework: Shaping education

and training for an effective and relevant workforce

15:3017:30 COVID - 19 Special/Joint Session 15:30

16:30

Cochrane Rehabilitation projects to improve your research

and clinical activities17:4018:40 INDUSTRY-SPONSORED SESSION

18:40 CLOSING

MONDAY 14

TUESDAY 15


8




SATU

RDAY

12

JUN

E

CEST ROOM 111:0012:00 PHARMACOLOGY OF POST-STROKE RECOVERY

11:0011:20

The use of drugs for boosting post-stroke motor recoveryIsabelle Loubinoux

11:2011:30

Q&AIsabelle Loubinoux

11:3011:50

The use of usual drugs during sub-acute periodPhilippe Marque

11:5012:00

Q&APhilippe Marque

12:0513:05

REHABILITATION FOR THE AGED: NUTRITION, EXERCISE AND OTHERSModerators: Mooyeon Oh-Park, Walter Frontera

12:0512:20

Metabolically aware rehabilitation for older peoplePaolo Capodaglio

12:2012:35

The optimal exercise prescription in the rehabilitation of the agedWalter Frontera

12:3512:50

Adequate Prescription, why matters?Eleftheria Antoniadou

12:5013:05

Q&AEleftheria Antoniadou, Mooyeon Oh-Park, Walter Frontera, Paolo Capodaglio

13:1514:15 THE ROLE OF REHABILITATION IN CRITICAL CARE SETTING

13:1513:35

Cardiopulmonary Rehabilitation for Patients in Critical CareYuan-Yang Cheng

13:3513:55

ICU-Acquired Weakness: Prevention and Rehabilitation Reynaldo R. Rey-Matias

13:5514:15

Incorporating Hybrid Telerehabilitation in the ICUCarl Froilan D. Leochico

14:2015:20 MEDICAL REHABILITATION IN PANDEMIC RESPONSE: A GLOBAL PRIORITY

14:2014:30

Rehabilitation Strategy for COVID-19Jianan Li

14:3014:40

Neurological manifestations and complications of COVID-19Farooq A. Rathore

14:4014:50

Developing ClinFIT COVID-19: an ISPRM initiative to scale up rehabilitation in a new world

Francesca Gimigliano, Melissa Selb, Masahiko Mukaino, Jianan Li, Leonard Li, Gerold Stucki

14:5015:00

COVID-19 response in low-resource settings: a Nepalese perspective

Raju Dhakal

15:0015:10

COVID-19 resonse in the USA and CanadaEric Morrison

15:1015:20

Q&ABhasker Amatya, Fary Khan


9




SATU

RDAY

12

JUN

E

CEST ROOM 115:3016:30 TELEMEDICINE IN CANCER REHABILITATION

15:3016:10

Telemedicine in Cancer RehabilitationPhilip Chang

16:1016:30

Q&APhilip Chang

16:3517:35 STEM CELL THERAPY IN ACUTE NEUROLOGICAL INJURY: THE NEW FRONTIER

16:3516:50

Human neural stem cell transplantation for acute ischemic brain injury

Xiaofeng Jia

16:5017:05

Current Status and Challenges of Stem Cells Regulating Microenvironment to Repair Spinal Cord Injury

Shiqing Feng

17:0517:20

The Impact of Astroglial Intermediate Filaments on Donor hNSC Fate and Efficacy in Injured Mammalian Spinal Cords

Yang D Teng

17:2017:35

Human adipose-derived stem cell treatment modulates cellular protection in both in vitro and in vivo traumatic brain injury models

Spencer Brown


10




CEST ROOM 1 CEST ROOM 211:0012:00 OPENING

11:0011:20

Welcome AddressLeonard Li, Francesca Gimigliano, Levent Özçakar

11:2011:40

Specificity of PRM: Time for a Unified Perspective on Biology and BehaviorLuigi Tesio

11:4012:00

Neuromodulation for Rehabilitation: State of the ArtFelipe Fregni

12:0513:05

ACUTE SETTING Moderators: Aydan Oral, Jorge Lains 12:05

13:08

ORAL PRESENTATIONS Moderators: Lidian Chen, Alain Yelnik

NON CME SESSION

12:0512:25

10 commandmentsHenk Stam

12:0512:14

Altered effective connectivity between the primary motor cortex and

frontoparietal cortex as indicators of impairment severity following stroke

H. Yang, H. Wang, M. Fan, J. Jia

12:2512:45

Intensive & Post-intensive CareFrans Nollet

12:1412:23

Effects of rtms combined with treadmill training on locomotor function and the

expressions of serotonin receptors in rats with spinal cord injury

S. Wang, R. Yin, P. Wang, T. Zhou, G. Xu, H. Wang

12:4513:05

Cardiopulmonary RehabilitationMatthew Bartels

12:2312:32

Comparison and evolution of 4 movement smoothness markers at stroke

subacute stage: a rem-avc ancillary study

G. Cornec, M. Lempereur, B. Medee, R. Gross, S. Bellaiche, O. Remy-Neris, N. Bayle

12:3212:41

Comparison of four smoothness markers for point-to-point upper limb movements

in healthy subjectsN. Bayle, M. Lempereur, E. Hutin,

O. Remy-Neris, J. Gracies, G. Cornec

12:4112:50

Estimating key gait events using leg kinematics for amputees: Assessment of accuracy against force plate data

Z. Aftab

12:5012:59

Comparison of exercise intensity during exergame, dual-task or single-task

training sessions: a pilot transversal studyM. Gallou-Guyot, A. Perrochon, R. Marie,

E. Digbeu-Labbe, S. Mandigout

12:5913:08

Ultrasound therapy effects on oxidative stress in knee osteoarthritis

R.A. Ungur, V.M. Ciortea, L. Irsay, S. Suciu, E.C. Craciun, E. Dronca, A.D. Ciubean,

I.M. Borda

SUN

DAY

13

JUN

E


11





13:1514:15

STROKE - I Moderators:

Isabelle Laffont, Peter Lim

13:1514:15

STROKE - IIModerators:

Toyoko Asami, Reynaldo Rey Matias

13:1513:35

Lesion Topography ImpactNachum Soroker

13:15 13:35

Paralympic BrainPablo A. Celnik

13:3513:55

Vagus Nerve StimulationGerard Francisco

13:35 13:55

Rehabilitation With GamesThierry Lejeune

13:5514:15

Long Term Follow-upKatharina S. Sunnerhagen

13:55 14:15

Rehabilitation With EEGMarco Franceschini

14:2015:20

SPINAL CORD INJURY Moderators:

Linamara R. Battistella, Piotr Tederko

14:2015:20

TECHNOLOGY - INNOVATIONModerators:

Milica Lazovic, Eiichi Saitoh

14:2014:40

Spinal Cord Stimulation: From the Benchside to the Bedside

Andrei Krassioukov

14:2014:40

Mobile Health Technology in Rehabilitation

Paolo Bonato

14:4015:00

Central and Peripheral Mechanisms of Epidural Spinal Cord Stimulation

David Darrow

14:4015:00

Innovations in TBI RehabilitationRoss Zafonte

15:0015:20

Spinal Motor and Autonomic Mapping by Epidural Stimulation:

Clinical ImplicationsJordan Squair

15:0015:20

Innovations in RoboticsJoel Stein

15:3016:30

SPASTICITYModerators:

Yvona Angerova, Nicola Smania

15:3016:30

SCOLIOSISModerators:

Veronica Matassa, Abdellatif Elfatimi

15:3015:50

Ultrasound Imaging for the Spastic Muscle

Alessandro Picelli

15:3015:50

Adolescents With Idiopathic ScoliosisStefano Negrini

15:5016:10

Innervation Zone Targeting: EUROMUSCULUS/USPRM Spasticity Approach

Bayram Kaymak

15:5016:10

Adults With ScoliosisÖzden Taşkıran

16:1016:30

Botulinum Toxin Dosing for Functional Achievements

Jorge Jacinto

16:1016:30

Parkinson's Disease and Pisa SyndromeLuciano Bissolotti

SUN

DAY

13

JUN

E


12





SUN

DAY

13

JUN

E

16:3517:35

LIMB LOSSModerators:

Carolina Schiappacasse, Nobuhiko Haga

16:3517:35

CEREBRAL PALSYModerators:

Naheed Vandewalle, Wilma Van der Slot

16:3516:55

Update/Evidence on Rehabilitation of People With Upper Limb Loss

Helena Burger

16:3516:55

Holistic CareInfant, Toddler, School-age

Rochelle Dy

16:5517:20

Update/Evidence on Rehabilitation of People With Lower Limb Loss

Hans Rietman

16:5517:20

Holistic CareAdolescent, Adult

Heakyung Kim

17:2017:35

Q&AHelena Burger, Hans Rietman

17:2017:35

Q&ARochelle Dy, Heakyung Kim

17:40 18:40 INDUSTRY-SPONSORED SYMPOSIUM 17:40

18:40 INDUSTRY-SPONSORED SESSION


13





11:0012:00

LOW PHYSICAL ACTIVITYModerators:

Ayşen Akıncı, Guy Vanderstraeten

11:0012:00

MEDICAL LEADERSHIP: THE WAY FORWARD

IN OVERCOMING ADVERSITIESCourse Director: Sam S. H. Wu

Moderators: Su Yi Lee, Manoj K. Poudel, Alessandro De Sire, Bryan O’Young

11:0011:20

ObesityPaolo Capodaglio

Panel Speakers: Toyoko Asami; Linamara Rizzo Battistella,Joel A. DeLisa, Rochelle T. Dy, Francesca Gimigliano, Juan M. Guzman Gonzalez,

Kurt Hoppe, Isabelle Laffont, Jorge Lains, Jianan Li, Jianjun Li, Leonard Li, Peter Lim, Veronica Matassa, Reynaldo Rey Matias,

John Melvin, William F. Micheo, Mooyeon Oh-Park, Zaliha Omar, Levent Özçakar,

Carolina Schiappacasse, Gregory Worsowicz

11:2011:40

Low Back PainMarta Imamura

11:4012:00

OsteoporosisAlberto Falchetti

12:0513:05

SPORTS Moderators:

Yetsa A. Tuakli-Wosornu, Nicolas Christodoulou

12:0513:05

ORAL PRESENTATIONS Moderators:

Catarina Aguiar Branco, John OlverNON CME SESSION

12:0512:25

For Whom, When and How?William Micheo

12:0512:14

Improving of the effectiveness of motor-imagery training with bci technology in hand exoskeleton

in post-stroke rehabilitationA. Rubakova, G. Ivanova, M. Bulatova, B. Polyaev

12:2512:45

ParalympicsJan Lexell

12:1412:23

Physical performance early after allogeneic hematological stem cell

transplantation (allo-hsct): a new challenge for rehabilitation

and exercise medicineV. Pinelli, A. Cordival

12:4513:05

InjuriesCheri Blauwet

12:2312:32

Breast cancer population in portuguese pmr services:

a 5-year multicentric cohort studyF.D. Rocha, J. Romano, O. Romano, T. Amaral,

L. Prates, F. Antunes, F. Gabriel, C. Ângelo, C. Gomes

MO

ND

AY 1

4 J

UN

E


14





12:3212:41

Nutrition management of amyotrophic lateral sclerosis - treatment strategies

to prevent malnutritionA. Paredes Coelho, L. Rovisco Branquinho,

J. Nuno Malta, J.P. Branco

12:4112:50

Effectiveness of a telerehabilitation program for covid-19 survivors (tereco)

on exercise capacity, pulmonary function, lower limb muscle strength, and quality

of life: a randomized controlled trialJ. Wang, J. Li, W. Xia, C. Zhan, S. Liu, Z. Yin,

Y. Chong, C. Zheng, X. Feng, W. Cheng, J.D. Reinhardt

12:5012:59

Correlation between postural balance, isokinetic trunk muscle strength

and the severity of women stress urinary incontinence

S. Ghroubi, N. Kallel, Y. Zribi, M. Ahmed, S. Abidi, M. Chlif, M.H. Elleuch

13:1513:45

AWARDS CEREMONY Moderators: Lynn Gerber, Walter Frontera

13:1513:45 Awards Ceremony

13:4514:15

Sidney Licht LectureMarta Imamura

14:1515:20 ISPRM Assembly of Delegates (AoD)

15:3016:30

USPRM TASK FORCEModerators:

Martine De Muynck, Levent Özçakar15:3016:33


Catherine Dziri, Jorge GutierrezNON CME SESSION

15:3015:50

Adding 'Sensation' to ExaminationVincenzo Ricci 15:30

15:39

Analysis of biofeedback based Balance training in patients with balance

disorders: a pre-post studyS. Saxena, M.S. Dhillo

15:5016:10

Examination in the Absence of 'Sensation'Kamal Mezian

15:3915:48

Functional status of patients with lower-limb amputation: a follow-up

home-based visitA. Thibaut, G. Cicchellero, C. Beaudart,

J. Kaux, B. Maertens de Noordhout, D. Pelzer

16:1016:30

Fasciae: Imaging and FurtherCarmelo Pirri

15:4815:57

Assessment of pelvic floor and abdominal muscles function among continent and

incontinent non-active womenS. Ghroubi, S. Abidi, O. Jelassi, H. Ben Ayed,

M. Chlif, M.H. Elleuch

MO

ND

AY 1

4 J

UN

E


15





MO

ND

AY 1

4 J

UN

EM

ON

DAY

14

JU

NE

15:5716:06

Impact of outpatient rehabilitation on non-motor signs in people

with parkinson’s disease. A retrospective cohort study

A. Lambertucci, P. Bisoglio, S. Ercoletti, L. Latini, M. Grugnetti, M. Hibel, E. Andrenelli,

M.G. Ceravolo, M. Capecci

16:0616:15

Osteosarcopenia and type 2 diabetes mellitus in post-menopausal women:

a case-control studyA. Moretti, M. Paoletta, S. Liguori,

F. Zanfardino, A. Battaglini, L. Giordano, G. Iolascon, F. Gimigliano

16:1516:24

Predicting anxiety in patients with post-concussion syndrome

J. Olver, B. Fedele, D. McKenzie

16:2416:33

Upward magnetic stimulation of nerve roots improves motor function

of spinal cord injury through sensorimotor cortex remodeling

Y. Zheng, D. Zhao, D. Xu

16:3517:35

ISARCOPRM SPECIAL INTEREST GROUP

Moderators:Xanthi Michail, Jae-Young Lim

16:3517:35


Melissa M. Guzman, Khalil AlabbadiNON CME SESSION

16:3516:55

Aging and Sarcopenia Research: An Update

Walter Frontera 16:3516:44

Eight weeks of high-intensity interval static strength training improves

skeletal muscle atrophy and motor function of aged rats via

a pgc-1 a/fndc5/ucp1 pathwayL. Fang

16:5517:20

Assessing Muscle Function and DisabilityJonathan Bean

16:4416:53

Prehabilitation, based on mixed physical activity, for patients with multiple

myeloma, during chemotherapy before autologous hematopoietic stem cells

transplantation (auto-hsct): safe and efficient

V. Pinelli, P. Cerutti, Y. Darolles, M. Roussel, B. Hebraud, A. Perrot

17:2017:35

Assesing Muscle Mass - ISarcoPRM Algorithm

Murat Kara16:5317:02

Microinvasive percutaneous needle tenotomy to treat neurological

foot deformations:a large retrospective study

F. Angioni, M. Salga, P. Denormandie, F. Genet, O. Haigh, R. David,

L. Gatin, A. Schnitzler


16





MO

ND

AY 1

4 J

UN

E

17:0217:11

Postural control and muscle activity during stand-to-sit movement

in individuals with knee osteoarthritisS. Fu, X. Wang

17:1117:20

An answer to covid-19 pandemic: cochrane rehabilitation reh-cover

(rehabilitation – covid-19 evidence-based response) action

M. Ceravolo, E. Andrenelli, C. Arienti, A. De Sire, F. Negrini, S. Lazzarini, M. Patrini,

C. Kiekens, S. Negrini

17:2017:29

Effects of computer game assisted task specific exercises on upper extremity functionality, cognitive function and quality of life in stroke patients: a

randomized control studyS. Ozen, H. Boluk Senlikci, S. Guzel

17:40 18:40 INDUSTRY-SPONSORED SYMPOSIUM


17





11:0012:00

INTERVENTIONS - I Moderators:

Dia Shehab, Henry Lew11:0012:00

CURRENT STATUS OF CHRONIC MYOFASCIAL PAIN SYNDROME:

EVIDENCE-INFORMED DIAGNOSIS AND MANAGEMENT

11:0011:20

Ultrasound-guided Injections: The EvidenceJorge Barbosa

11:0011:05

Current criteria for diagnosis of myofascial pain and challenges

Lynn Gerber

11:2011:40

Ultrasound-guided Suture Injections in Migraine

Merve Sekizkardeş 11:0511:15

Current state of research characterizing the pathophysiology of myofascial pain

- Contribution of fascia to the clinical presentation of myofascial pain

Antonio Stecco

11:4012:00

Ultrasound-guided Peripheral Nerve Injections

Simao Serrano 11:1511:25

Current state of research characterizing the pathophysiology of myofascial

pain - Neurogenic Hypothesis: the role of central sensitization and neurogenic

inflammationJohn Srbely

11:2511:50

Current clinical examination of the myofascial pain patient -

Examination, objective and PROsSecili DeStefano, Jay Shah,

Antonio Stecco, Siddhartha Sikdar

11:5012:00

What is the evidence for effective treatment of the patient

with myofascial painSecili DeStefano, Dinesh Kumbhare

12:0513:05

INTERVENTIONS - IIModerators:

Sara Laxe, Nitin Jain 12:0513:05

ADVANCED CONCEPTS AND REHABILITATION APPROACHES

FOR CHRONIC PELVIC PAIN IN WOMEN Moderators:

Areerat Suputtitada, Carl PC Chen

12:0512:25

Ultrasound-guided Pharyngeal Injections in Dysphagia

Chueh-Hung Wu

12:0512:10

IntroductionAreerat Suputtitada, Carl PC Chen

12:2512:45

Ultrasound-guided Spinal Injections

Ke-Vin Chang

12:1012:20

Tips of Diagnosis and Treatment of Chronic Pelvic Pain in Women

Areerat Suputtitada

12:4513:05

Ultrasound-guided Regenerative Injections

Gi-Young Park

12:2012:30

Sensitization of Pelvic Pain in Women Bryan O’ Young

12:3012:40

Ultrasound Intervention Technique for Chronic Pelvic Pain: Gender difference

Carl PC Chen

TUES

DAY

15

JU

NE


18





12:4012:50

Telerehabilitation of Chronic Pelvic Pain in Women During COVID-19

Marta Imamura

12:5013:05

Interesting Cases and Q&AAll speakers

13:15 14:15

INTERVENTIONS - IIIModerators:

Mooyeon Oh-Park, Simon Tang 13:15 14:15

THE ISPRM STRATEGY TO COLLABORATE WITH THE

WORLD HEALTH ORGANIZATION; THE ISPRM WHO LIAISON COMMITTEE

ACTIVITIES REPORT

13:1513:35

Ultrasound-guided Radiofrequency Ablation

Nimish Mittal

13:1514:15

Panel Speakers: Julia P. Engkasan, Carlotte Kiekens,

Christoph Gutenbrunner, Masahiko Mukaino13:35

13:55

Ultrasound-guided Extracorporeal Shock Wave Therapy

Nikolaos Barotsis

13:5514:15

Ultrasound-guided Minor SurgeryAmit Bhargava

14:2015:20

AN INTRODUCTION TO CANCER REHABILITATION FROM THE ADVOCACY,

CLINICAL PRACTICE, EDUCATION, AND RESEARCH PERSPECTIVES

14:2015:20

WHO REHABILITATION COMPETENCY FRAMEWORK: SHAPING EDUCATION AND TRAINING FOR AN EFFECTIVE

AND RELEVANT WORKFORCE14:2014:30

IntroductionVishwa Raj

14:2015:20

Panel Speakers:Rochelle Dy,

Jody-Ann Mills, Maria Gabriela Ceravolo,

Mooyeon Oh-Park

14:3014:40

AdvocacyCynthia Bennett, Swatee Jena

14:4014:50

Clinical PracticeKrystal Song, Abderrazak Hajjioui

14:5015:00

EducationChris Custodio, Birgit Leibbrand

15:0015:10

ResearchMonica Pinto, Jae Yong Jeon

15:1015:20

Closing StatementsVishwa Raj

TUES

DAY

15

JU

NE


19





15:3017:30

COVID - 19 SPECIAL/JOINT SESSIONModerators:

Abderrazak Hajjoui, Rory Cooper, Bryan O’Young, Dianne Davis

15:3017:30

COCHRANE REHABILITATION PROJECTS TO IMPROVE YOUR RESEARCH AND

CLINICAL ACTIVITIES Moderators:

Francesca Gimigliano, Farooq A. Rathore

Impact of COVID-19 on Health-related lifestyle behaviors in persons with disabilities worldwide

15:3015:50

Reporting Guidelines for rehabilitation studies: the RCTRACK project results

Stefano Negrini

15:3015:35

IntroductionsAbderrazak Hajjioui, Rory Cooper 15:50

16:10

A rehabilitation definition for useful for research purposes: results of the

Cochrane Rehabilitation projectCarlotte Kiekens

15:3515:45

Impact of the COVID-19 Pandemic on health-related lifestyle behaviors

among the general population worldwideBo Young Hong

16:1016:30

The REH-COVER REHabilitation - COVID-19 Evidence-based Response

action of Cochrane RehabilitationMaria Gabriella Ceravolo

15:4515:55

Impact of the COVID-19 Pandemicon health-related lifestyle behaviors among the people with disabilities

around the worldYetsa Tuakli-Wosornu

15:5516:05

Women, disability, and healthy lifestyle during the COVID-19 pandemic

Maryam Fourtassi

16:0516:15

Patients with non-communicable diseases, disability, and healthy lifestyle during

the COVID-19 pandemicAbderrazak Hajjioui

16:1516:25

Impacts of COVID-19 on the population with disabilities in Latin America

Laura Paulina Muñoz-Velasco

16:2516:30

Interactive Discussion and Panel Questions

All speakers

COVID-19 and Beyond: An ISPRM and UN Partnership in Enhancing the Well-being

of the Aging Population

16.3017:30

Panel Speakers: Akiko Ito, Alexandre Sidorenko, Naheed Van de Walle, Sam Wu,

Areerat Suputtitada, Bryan O’Young, Dianne Davis

17:40 18:40 INDUSTRY-SPONSORED SESSION

18:40 CLOSING

TUES

DAY

15

JU

NE


20




Format:The Virtual ISPRM 2021 Congress will take place online as a virtual event from 12-15 June 2021. Registered delegates can access the Virtual ISPRM Congress by using the login details received by the Organizing Secretariat 5 days before the Congress’ start.

All sessions in the scientific program will take place live and interactive at the time indicated in the program (all references to a date or deadline mentioned here refer to the Central European Time Zone (CEST).Recordings of all sessions will be available afterwards: access will be limited to registered delegates until 15 December 2021.

Registration:Registration procedures are available on the official Virtual ISPRM 2021 Congress website www.virtualisprm2021.com

Technical requirements:Delegates must ensure at their own expenses that they meet the technical requirements necessary for participation in the Virtual ISPRM 2021 Congress.In addition to the necessary hardware, the following requirements will be needed:• A stable internet connection with a minimum of 5 MBITs (data speed) to follow the online program,• A browser in an up-to-date version e.g. Chrome©, Firefox© or Safari©.

ISPRM recommends the participation via PC/Mac Computers and a resolution of Full HD 1920x1080 pixels or higher. Cookie and Pop-Up blocking measures may lead to problems. On smartphone/tablet devices only basic viewing features are being supported. It is recommended to use the Safari© browser for Apple©devices.ISPRM is not responsible if delegates are unable to successfully access the Virtual ISPRM 2021 Congress if they do not fulfil the technical requirements.

Delegates receive:• Admission to live-streamed and recorded Scientific Program• Admission to the virtual Industry Exhibition• Admission to interactive chat/discussion Lounge Area

Certificate of attendance:Certificates will be available for download from the Account section of the Congress’ platform, starting from June 15 th, 2021 onwards.

UEMS/EACCME® accreditationThe Virtual ISPRM 2021 Congress, Milano, Italy, 12/06/2021-15/06/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 20 European CME credits (ECMEC®s).Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.” “Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRACategory 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

We will track attendance of attendees each day during the congress. Each participant can only receive the number of credits he/she is entitled to according to his/her actual participation at the event once he/she has completed the Evaluation Form that could be filled online in a dedicated section of the platform.The Feedback Form must be filled exclusively from June 22th to June 29th, 2021. The UEMS certificate reflecting the actual attendance can be downloaded following the form.

GEN

ERA

L IN

FORM

ATIO

N


21




Please find below the breakdown of ECMEC®s per day:June 12th, 2021 - 6.00 CME CreditsJune 13th, 2021 - 5.00 CME CreditsJune 14th, 2021 - 4.00 CME CreditsJune 15th, 2021 - 5.00 CME CreditsThe EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day.

Presenters and Chairpersons:All sessions in the scientific program will take place live and interactive at the time indicated in the program schedule. Symposia and OP presenters should present live and participate in follow-up Q&A session. All presenters and chairpersons will receive detailed instructions and will be invited to individual trial presentations with technical staff prior to the Virtual ISPRM 2021 Congress to test the presentation and Q&A system. In case of any questions, please contact: [email protected].

Posters:Every author must submit its poster in PDF format. On the platform where posters will be displayed, every participant will be able to: • Search a poster using few keywords, such as topic, authors, title, code• Zoom in/out to see the details• Type messages or questions to the Authors searching them in the Lounge Area Chat

Abstract Selection:All abstracts accepted for inclusion in the scientific program were considered anonymously and were scored by 30 Congress Scientific Committee Members. Congress Scientific Committee Members designed the program and created Oral and Poster Sessions based upon the anonymous abstracts.

Publication of Abstracts:Accepted abstracts will be published in the the Journal of the International Society of Physical and Rehabilitation Medicine (JISPRM).

Exhibition:For the duration of the Virtual ISPRM 2021 Congress, delegates receive access to the virtual Industry Exhibition.

Please note that:Exhibition is intended for healthcare professionals registered to attend the Virtual ISPRM 2021 Congress only. Participants to the virtual conference should refer to the official prescribing information (or Summary of Product Characteristics [SmPC]) for each referenced product in the relevant jurisdiction for information on approved indications, contraindications, and warnings. By choosing to access the Exhibition Area delegates confirm that are HCP.

Disclaimer:All efforts will be made to adhere to the program as provided. However, ISPRM and its agents reserve the right to alter or cancel, without prior notice, any of the arrangements, timetables, plans or other items relating directly or indirectly to the Meeting, for any case beyond their reasonable control.ISPRM and conference organizers are not liable for any other loss or inconvenience caused as a result of such changes.

GEN

ERA

L IN

FORM

ATIO

N


https://www.jisprm.org/

https://www.jisprm.org/

22




IND

UST

RY-S

PON

SORE

D S

ESSI

ON

S

CEST ROOM 117:40 18:40

ALLERGAN SYMPOSIUM:Achieving early identification of post-stroke spasticity

17:4017:45

Welcome & Introduction Jörg Wissel

17:4518:05

Importance of early identification of post-stroke spasticityGanesh Bavikatte

18:0518:25

Predicting post-stroke spasticity Jörg Wissel

18:2518:35

Questions & Answers Ganesh Bavikatte, Jörg Wissel

18:3518:40

Summary Ganesh Bavikatte, Jörg Wissel

CEST ROOM 2

17:40 18:40

IPSEN MEET THE EXPERT:Injector Training session

(this session is intended for Physicians only)Dr Jorge Jacinto, Julie Tiley

SUNDAY 13

CEST ROOM 1

17:40 18:40

IPSEN SYMPOSIUM:Adult spasticity: why are so few patients treated with botulinum toxin?

(this session is intended for Physicians only)Alberto Esquenazi, Urban Fietzek

MONDAY 14

CEST ROOM 2

17:40 18:40

MERZ SYMPOSIUM:Better patient outcomes in upper limb spasticity.

Comprehensive treatment approaches, clinical experience and best practicesLuis Jorge Jacinto

17:4017:55

Achieving patient goals with multi-pattern treatment of the upper limbJörg Wissel

17:5518:25

Clinical cases: Let’s talk about shoulder treatment and opportunitiesDamon Hoad, Alexandre Camões Barbosa, Stefano Carda

18:2518:40

Panel discussion: Pragmatic approachesLuis Jorge Jacinto, Damon Hoad, Alexandre Camões Barbosa, Stefano Carda

TUESDAY 15


What is your goal with your patients? Let’s take comprehensive BoNT therapy to the NEXT level, together.XEOMIN®, 50, 100 or 200 units, powder for solution for injection. Active substance: Clostridium botulinum neuro-toxin type A (150 kD), purified from Clostridium botulinum cultures (Hall strain), free from complexing proteins. Prescription-only medicine! Qualitative and quantitative composition: One vial contains: 50, 100 or 200 units of Clostridium botulinum neurotoxin type A (150 kD), free from complexing proteins, human albumin, sucrose. Due to the differences in the potency assays, unit doses are not interchangeable with those for other Botulinum toxin type A preparations. Therapeutic indications: For the symptomatic treatment in adults of: blepharospasm, and hemifa-cial spasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis), spasticity of the upper limb, and chronic sialorrhea due to neurological disorders. Contraindications: Hypersensitivity to the active substance or to any of the excipients, generalised disorders of muscle activity (e.g. myasthenia gravis, Lambert-Eaton syndrome), infection or inflammation at the proposed injection site. Do not use during pregnancy unless clearly necessary. Do not use during breast-feeding. Undesirable effects: Undesirable effects usually occur within the first week following injection and are temporary in nature. They may be related to the active substance, the injection procedure, or both. Application related: Localised pain, inflammation, paraesthesia, hypoaesthesia, tenderness, swelling, oedema, ery-thema, itching, localised infection, haematoma, bleeding and/or bruising. Needle related pain and/or anxiety may result in vasovagal responses, including transient symptomatic hypotension, nausea, tinnitus and syncope. Local-ised muscle weakness is one expected pharmacological effect of Botulinum toxin type A. Toxin spread: Undesirable effects related to spread of toxin distant from the site of administration have been reported very rarely to produce symptoms consistent with Botulinum toxin type A effects (excessive muscle weakness, dysphagia, and aspiration pneumonia with a fatal outcome in some cases). Hypersensitivity reactions: Rare reports of serious and/or imme-diate hypersensitivity reactions including anaphylaxis, serum sickness, urticaria, soft tissue oedema, and dyspnoea, sometimes either following the administration of conventional Botulinum toxin type A complex preparations alone or in combination with other active substances known to cause similar reactions. The following undesirable ef-fects were observed with the clinical use of XEOMIN®: Very common (≥1/10); common (≥1/100 to <1/10); uncom-mon (≥1/1,000 to <1/100). Blepharospasm: Very common: Eyelid ptosis; Common: Dry eyes, vision blurred, visual impairment, dry mouth, injection site pain; Uncommon: Headache, facial paresis, diplopia, lacrimation increased, dysphagia, rash, muscular weakness, fatigue. Hemifacial spasm: Similar adverse reactions as for blepharospasm. Spasmodic torticollis: Very common: Dysphagia: dysphagia of varying degrees of severity may cause aspiration which may require medical intervention. Duration: 2-3 weeks post-injection, in one case up to 5 months; Common: Upper respiratory tract infection, headache, presyncope, dizziness, dry mouth, nausea, hyperhidrosis, neck pain, muscular weakness, myalgia, muscle spasms, musculoskeletal stiffness, injection site pain, asthenia; Uncommon: Speech disorder, dysphonia, dyspnoea, rash. Spasticity of the upper limb: Common: Dry mouth; Uncommon: Head-ache, hypoaesthesia, dysphagia, nausea, muscular weakness, pain in extremity, myalgia, asthenia; Frequency not known: Injection site pain. Chronic sialorrhea: Common: Paraesthesia, dry mouth, dysphagia; Uncommon: Speech disorder, altered (thickened) saliva, dysgeusia. Cases of persistent dry mouth (> 110 days) of severe intensity have been reported with possible complications as gingivitis, dysphagia and caries. Post-marketing experience: Fre-quency not known: Hypersensitivity reactions like swelling, oedema (also distant from the injection site), erythema, pruritus, rash (localised and generalised), breathlessness, muscle atrophy, flu-like symptoms. Further information is provided in the Summary of Product Characteristics and the Package Leaflet. PLEASE CHECK YOUR LOCAL APPROV-AL STATUS. Merz Pharmaceuticlas GmbH, 60048 Frankfurt/Main, Germany. Date of revision of the text: February 2020Merz Therapeutics is a business of Merz Pharmaceuticals GmbH.

I HAVE A GOAL

Visit our symposium on June 15th, 5:40 pm CEST

My goal is to use the computer with my right arm again.

Emmanuel, 44Spasticity patient

24




PLATINUM

GOLD

ACK

NO

WLE

DG

MEN

TS

Inter Reha

Teijin

Tirr Memorial Hermann

Toyota Motor Corporation

Tomei Brace


25




Organizing SecreteriatFlorence OfficeViale G. Mazzini, 7050132 Florence, ItalyPh. +39 055 233881Fax +39 055 [email protected]

Faculty Management Milan OfficeVia Giuseppe Ripamonti, 12920141 Milan, ItalyPh. +39 02 566 011Fax +39 02 566 [email protected]

RegistrationRome OfficeVia Flaminia, 106800189 Rome, ItalyPh. +39 06 330 531Fax +39 06 330 [email protected]

Abstract ManagementMilan OfficeVia Giuseppe Ripamonti, 12920141 Milan, ItalyPh. +39 02 566 011Fax +39 02 566 [email protected]

CON

TACT

S

Alberto Esquenazi & Urban FietzekJune 14th | Room 1 | 17:40-18:40 CET

Alberto Esquenazi: Physical Medical and Rehabilitation Specialist, MossRehab & Albert Einstein Medical Center, Elkins Park, PA, USA.Urban Fietzek: Neurologist, Schön Klinik München Schwabing, Dept. of Neurology and Clinical Neurophysiology, Munich, Germany.

Job code: DYS-DE-001163 | Date of preparation: May 2021

IPSEN SPONSORED SATELLITE SYMPOSIUMVIRTUAL ISPRM 2021 CONGRESS

ADULT SPASTICITY

WHY ARE SO FEW PATIENTS TREATED WITH

BOTULINUM TOXIN?


Documents

VIRTUAL ISPRM 2021 · 2021. 6. 1. · 2 VIRTUAL ISPRM 2021 Congress Furthering Rehabilitation in a New World WELCOME Dear ISPRM members, Colleagues and Friends, On behalf of the President’s